BiotechTube
Home/Lomond Therapeutics/John Byrd
JB

John Byrd

Interim Chief Medical Officer

Lomond Therapeutics

Roles

Interim Chief Medical OfficeratLomond Therapeutics
Interim Chief Medical OfficeratEilean Therapeutics

Therapeutic Areas

OncologyHematology

Lomond Therapeutics Pipeline

DrugIndicationPhase
lomonitinibAcute Myeloid Leukemia (AML)IND-Enabling
lonitoclaxChronic Lymphocytic Leukemia (CLL)Phase 1
Menin InhibitorAcute Myeloid Leukemia (AML)Discovery

Leadership Team at Lomond Therapeutics

ID
Iain Dukes
CEO
NS
Nikolay Savchuk
COO
AB
Amy Burd
CSO
BL
Brian Ledwith
Chief Development Officer
FP
Fraser Pickersgill
Head CMC
View full Lomond Therapeutics profile